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Matrilysin Shedding of Syndecan-1 Regulates
Chemokine Mobilization and Transepithelial
Efflux of Neutrophils in Acute Lung Injury
of matrilysin in healthy epithelium suggests that it func-
tions in a common homeostatic process among epithe-
lia, which seems to be defense against microorganisms.
In mice, matrilysin activates intestinal pro--defensins,
a family of antimicrobial peptides, and due to the lack
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Saint Louis, Missouri 63110 of mature -defensins, matrilysin null mice have an im-
paired ability to battle enteric pathogens (Wilson et al.,2 Section of Infectious Diseases
Department of Medicine 1999). Another function of epithelial-derived matrilysin
is generating soluble Fas ligand (Mitsiades et al., 2001;Baylor College of Medicine
Houston, Texas 77030 Powell et al., 1999), a processing event that has been
linked to tumor progression (Crawford et al., 2002; Fin-
gleton et al., 2001). In addition to being produced in
intact tissues, matrilysin is expressed in migrating epi-Summary
thelium in injured airway (Dunsmore et al., 1998) and
intestine (Saarialho-Kere et al., 1996), suggesting thatThe influx of inflammatory cells to sites of injury is
largely directed by signals from the epithelium, but this MMP also functions in epithelial repair. Indeed, in
wild-type tissue, trachea wounds repair rapidly, whereashow these cells form chemotactic gradients is not
known. In matrilysin null mice, neutrophils remained wounds in matrilysin null tissue show no evidence of
epithelial migration, even several days post injury (Duns-confined in the interstitium of injured lungs and did
not advance into the alveolar space. Impaired transep- more et al., 1998). In fact, matrilysin-deficient mice have
the most severe wound repair defect among the MMPithelial migration was accompanied by a lack of both
shed syndecan-1, a heparan sulfate proteoglycan, and knockout mice generated to date (Parks, 1999; Parks
and Shapiro, 2001).KC, a CXC chemokine, in the alveolar fluid. KC was
bound to shed syndecan-1, and it was not detected in Because matrilysin is needed for the closure of muco-
sal wounds, we reasoned that matrilysin null mice wouldthe lavage of syndecan-1 null mice. In vitro, matrilysin
cleaved syndecan-1 from the surface of cells. Thus, be more susceptible to severe tissue injury. After all, if
re-epithelialization is impaired, then excessive fibrosis,matrilysin-mediated shedding of syndecan-1/KC com-
plexes from the mucosal surface directs and confines due to continued exudation of interstitial fluids, granula-
tion tissue formation, and fibroblast migration, wouldneutrophil influx to sites of injury.
ensue. We tested this idea using the bleomycin-induced
model of lung fibrosis. Bleomycin, instilled intratra-Introduction
cheally, causes rapid and extensive alveolar epithelia
damage, followed by severe, persistent inflammationDespite their specialization to serve distinct functions,
the epithelia of different tissues respond similarly to and fibrosis. Unexpectedly, matrilysin null mice were
markedly protected against the lethal and, to a lesserinjury and infection and regulate inflammation by equiva-
lent mechanisms. By forming a barrier and releasing extent, fibrotic effects of bleomycin-induced injury, and
this protection was associated with a significant reduc-antimicrobial products, epithelia provide the first line of
defense against invading pathogens. Following injury, tion in the number of neutrophils that moved into the
alveolar space. We demonstrate that matrilysin gener-epithelial cells initiate a programmed series of coordi-
nated responses, such as proliferation, migration, and ates a transepithelial gradient of KC, a CXC chemokine,
by ectodomain shedding of syndecan-1, the predomi-differentiation, to restore tissue integrity. By their pro-
duction of chemoattractants, adhesion molecules, and nant heparan sulfate proteoglycan on epithelia. Our find-
ings identify in vivo a specific sheddase for a syndecan,other proteins, epithelial cells recruit and confine inflam-
matory cells to sites of injury. Though seemingly diver- a substrate for matrilysin, and syndecan-1 as a binding
partner for KC. They also reveal an in vivo mechanismgent processes, the epithelial programs regulating re-
pair, defense, and inflammation may have coevolved, of how the epithelium controls and confines inflamma-
tion to sites of injury through the activity of three compo-particularly with respect to the genes selectively in-
duced. After all, injury provides an opportunity for infec- nents: matrilysin, syndecan-1, and KC.
tion, and infection can lead to injury, and both events are
proinflammatory. Hence, many of the epithelial products Results
associated with any one of these events are likely com-
mon to all. Matrilysin (MMP-7), a matrix metalloprotein- Matrilysin Deficiency Confers Protection
ase (MMP), is an example of a protein that functions in against Severe Lung Injury
defense, repair, and as shown here, inflammation. Matrilysin mRNA and protein were barely detectable
Matrilysin is produced by the epithelium of several in control mouse lungs (Figures 1A and 1E). Following
non-injured, non-inflamed tissues, such as lung, liver, instillation with 0.04 U bleomycin, matrilysin mRNA was
and breast (Wilson and Matrisian, 1998). The expression induced and increased over the next 15 days (Figure
1A), and prominent staining for the protein was seen on
the surface of alveolar epithelial cells, particularly those3 Correspondence: parks_w@kids.wustl.edu
Cell
636
Figure 1. Response to Instilled Bleomycin
WT and MAT/ mice were instilled intratracheally with 0.04 U bleomycin or saline.
(A) Matrilysin (MMP-7) and GAPDH mRNAs were detected by RT-PCR/Southern hybridization of RNA from control (day 0) and bleomycin-
instilled WT lungs. Only baseline signal was detected in saline-instilled mice. No product was seen in control reactions lacking reverse
transcriptase (data not shown).
(B) BAL was collected from WT and MAT/ (KO) lungs, and total protein was quantified. Data are the mean  SD (n  6). Other than at 16
hr and 1 day, the amount of protein in MAT/ BAL was significantly less than that in WT BAL at all points (p  0.02).
(C) Hydroxyproline content was assayed in the insoluble matrix. Data were converted to total collagen and are the mean  SD (n  3–8 mice
per point).
(D) Lung sections were stained with Masson’s trichrome. At 5 days post-bleomycin, perivascular infiltrates (arrowheads) were seen in both
WT and MAT/ (KO) lungs. In WT mice, infiltrates had progressed from the perivascular space into surrounding alveoli, but in MAT/
lungs, the infiltrating cells accumulated within an expanded perivascular compartment (arrowhead).
(E) Sections of control and bleomycin-instilled WT lungs were stained with a rat monoclonal against matrilysin and a FITC secondary antibody.
Only background fluorescence was seen in control sections (D0). Signal for matrilysin protein was seen in alveolar epithelial cells (arrows) at
1 (D1) and 3 (D3) days post-bleomycin. Fluorescence for matrilysin was strongest along the cell perimeter and on cell extensions spreading
over denuded tissue, such as marked by asterisks in the D3 image. These areas are shown under higher magnification at the far right.
bordering denuded regions (Figure 1E). To assess the protein levels were lower in MAT/ mice compared
to WT animals (Figure 1B).role of matrilysin in mucosal injury, we compared the
effects of bleomycin-instillation between wild-type (WT) Bleomycin mediates focal injuries, and discreet sites
of inflammation and nascent fibrosis were seen in bothand matrilysin null (MAT/) mice. MAT/ mice are
healthy, with normal growth, reproduction (Wilson et WT and MAT/ mice at 5-days postinstillation (Figure
1D). Total insoluble collagen, a marker of fibrosis, in-al., 1997, 1999), and lung morphology. Due to mucosal
injury, protein in broncho-alveolar lavage (BAL) in- creased progressively following bleomycin but was not
markedly different between MAT/ and WT mice overcreased over the first week post-bleomycin, but BAL
Matrilysin Sheds Syndecan-1
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Figure 2. Reduced Mortality in MAT/ Mice
(A) WT and MAT/ mice (n  10) were instilled with the indicated concentrations of bleomycin, and mortality was followed over the next
30 days.
(B and C) Lungs of WT and MAT/ (KO) mice were harvested 16 or 24 hr after instillation with 0.08 U (B) or 0.16 U (C) bleomycin and were
perfused with saline under airway pressure. Arrowheads mark a few areas of hemorrhage seen on the surface of the WT lungs.
the first 10 days postinstillation (Figure 1C). At later regulates a potentially lethal process during the acute
phase of injury. TNF, a key factor mediating bleomycin-times, collagen accumulated at a slightly reduced rate
in MAT/ animals. Regardless, extensive fibrosis was induced fibrosis (Ortiz et al., 1998; Piguet et al., 1989),
is activated by matrilysin in cultured macrophages (Haroseen at 15–30 days postinstillation in all mice (Figure
1D). Consistent with the collagen levels, alveolar fibrosis et al., 2000). However, we found no difference in the
levels of total or active TNF in BAL, lung extract, orwas typically less extensive in MAT/mice compared
to WT animals, particularly at later times. blood between WT and MAT/ mice at any time after
bleomycin (data not shown). Matrilysin can release FasThe BAL protein and collagen data indicated that bleo-
mycin caused less injury in MAT/ mice compared to ligand (Powell et al., 1999); however, a role for Fas li-
gand-mediated apoptosis in bleomycin-induced fibrosisWT mice. To explore further this unexpected response,
we instilled mice with various concentrations of bleomy- is controversial (Aoshiba et al., 2000; Kuwano et al.,
1999). Regardless, we detected no difference in the lev-cin and tracked their survival over the next 30 days. At
all doses, MAT/ mice were protected against bleo- els of soluble Fas ligand or the number of apoptotic
cells between bleomycin-instilled WT and MAT/mycin-induced lethality. At the higher doses (0.08 and
0.16 U), most WT mice were dead by 10 days after mice (data not shown). The prominent phenotype in
MAT/mice was impaired transepithelial influx of neu-instillation, while most MAT/ mice were still alive
(Figure 2A). Furthermore, within 24 hr of instillation with trophils.
In bleomycin-treated WT lungs, inflammatory cells in-0.08 or 0.16 U bleomycin, hemorrhage (Figures 2B and
2C), and cell debris (Figures 3A and 3B) were evident filtrated from the perivascular space into the lumen of
nearby alveoli (Figure 1D). In contrast, inflammatory cellsin WT lungs and BAL, respectively, but not in samples
from MAT/ mice. in MAT/ lungs were huddled within the perivascular
space and, for the most part, had not moved into sur-
rounding alveoli (Figure 1D). We then examined earlierImpaired Neutrophil Influx
We did not think that the slight reduction in fibrosis in times using a higher dose of bleomycin (0.16 U) to max-
imize differences between mouse strains. In BAL fromthe later phases led to protection against bleomycin-
induced lethality. Rather, we reasoned that matrilysin WT mice 16 hr post-bleomycin, we saw several neutro-
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Figure 3. Reduced Neutrophil Influx into the
Alveolar Space of MAT/ Mice
Lungs and BAL from WT and MAT/ (KO)
mice were harvested from control animals (0
days) and at various times (16 hr to 5 days)
postinstillation with 0.16 U bleomycin.
(A) At 16 hr post-bleomycin, BAL from WT
mice contained numerous neutrophils, as
well as a few macrophage and cell debris, (B)
whereas BAL from MAT/ mice contained
an abundance of macrophages, few neutro-
phils, and essentially no debris.
(C–F) Leukocytes were isolated from BAL and
lung extracts and counted. Neutrophils
(PMNs) are expressed as a percent of total
leukocytes (C and D) or as total cells per lung
(E and F). Data are the mean  SD (n  6).
(G) WT and MAT/ mice (n  10) were in-
stilled with saline or 0.04 U bleomycin with or
without nFNLP, and mortality was assessed
over the next 29 days.
(H) Leukocytes were isolated at 16 and 48 hr
from the BAL of MAT/ mice instilled with
saline (S), nFNLP (nF), or bleomycin and
nFNLP (BF) and counted.
phils, some macrophages, and cell debris (Figure 3A). cytes did not differ between WT and MAT/mice (data
not shown). These data indicate that although roughlyHowever, in the 16 hr BAL of MAT/ mice, we saw
few neutrophils, an abundance of macrophages, and the same number of neutrophils emigrated into MAT/
and WT lungs soon after injury, these cells had an im-essentially no debris (Figure 3B). From 1–5 days post-
bleomycin, the number of neutrophils recovered in paired ability to advance from the interstitium into the
lumenal compartment in the absence of matrilysin. Be-BAL—expressed as either percent of total leukocytes or
as total neutrophils—was consistently less in MAT/ cause matrilysin is not expressed by murine neutrophils,
macrophages, or interstitial cells, the defect in neutro-mice than in WT mice (Figures 3C and 3E).
The total neutrophils isolated from lung tissue of bleo- phil migration must be due to an epithelial-derived
process.mycin-instilled mice was about 3–4 logs greater than
the number found in BAL (Figures 3E and 3F) and was
not markedly different between WT and MAT/ mice Forced Neutrophil Influx Restores Lethality
To assess if the protective response seen in MAT/(Figures 3D and 3F). However, the percent of neutrophils
in the lung at 16 hr and 1 day post-bleomycin was slightly mice was due to impaired transepithelial influx of neutro-
phils, we instilled n-formyl-nle-leu-phe (nFNLP), a potentgreater in MAT/ mice than in WT animals (Figure
3D), consistent with more macrophages moving into neutrophil chemotactic peptide, with 0.04 U bleomycin.
At this dose, about 30%–50% of WT and 10%–20% ofthe alveolar space. Furthermore, about 20%–40% more
neutrophils were detected in MAT/ lungs at 3–5 days knockout mice died within 15 days (Figures 2A and 3G).
When coinstilled with nFNLP, bleomycin led to the deathpostinstillation with 0.16 U bleomycin (Figure 3F). These
data were confirmed by measuring myeloperoxidase ac- of essentially all MAT/ mice, but this combination
only modestly increased the lethality of WT animals (Fig-tivity in lung extracts (data not shown). The number of
circulating neutrophils, monocytes, and other leuko- ure 3G). In bleomycin-treated MAT/ mice, nFNLP
Matrilysin Sheds Syndecan-1
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Figure 4. Limited Neutrophil Migration in MAT/ Mice
WT and MAT/ mice were instilled 0.08 or 0.16 U bleomycin, and lungs were harvested 1–5 days later, fixed, and embedded. In each image,
the lumen of a nearby venule is marked (*).
(A–C) Sections of day 1 lungs were incubated with GR-1, an antibody specific for murine neutrophils. In WT lungs, many neutrophils (brown
stain; green arrowheads) were seen unattached within the alveolar space. In MAT/ lungs, several neutrophils were seen but only in close
apposition to the alveolar walls and not free within the lumen. Under higher magnification (C), stained neutrophils (cyan in this reverse image
of the boxed area in B) were seen within the alveolar wall.
(D–I) Sections of day 3 and 5 lungs were stained with hematoxylin/eosin or Masson’s trichrome (F and G). In all images, the border between
the perivascular and alveolar compartments is marked by red arrowheads; neutrophils that have migrated into the alveoli are indicated by
green arrows. In WT lungs, some neutrophils were seen within the perivascular space, but most had moved well into alveolar area. In MAT/
mice, neutrophils were confined to the perivascular space.
mediated an influx of neutrophils comparable to that were seen confined within the alveolar walls and not on
the lumenal side of the mucosal surface.seen in bleomycin-treated WT mice (Figure 3H). These
findings demonstrate that with an appropriate signal At 3 and 5 days post-bleomycin, a similar yet morpho-
logically distinct phenotype was seen. In WT mice, neu-neutrophils from MAT/mice can move through tissue
as effectively as do WT cells. In addition, once neutro- trophils (and lymphocytes) had migrated from the peri-
vascular space into the parenchymal compartment andphils were recruited into the alveolar space, MAT/
mice were more susceptible to injury, as we originally were seen loose within the alveolar lumen (Figures 4D
and 4F, green arrows). By 5 days postinstillation, morepredicted.
neutrophils had moved into lung tissue and had infil-
trated deeper into the alveolar compartment, and an
Confined Influx of Neutrophils into MAT/ Lungs even more profound inflammatory response was seen
To localize neutrophils, we stained lung sections with in WT lungs instilled with 0.16 U bleomycin (Figure 4H).
GR-1, an antibody specific for murine neutrophils. In WT In contrast, infiltrating neutrophils were confined to an
lungs, neutrophils were mostly seen within the lumen of expanded perivascular space in 3- and 5-day MAT/
alveoli (Figure 4A). Because lungs were lavaged before lungs, and only occasional cells were seen within the
fixation, the number of neutrophils seen in the alveolar alveolar areas (Figures 4E, 4G, and 4I).
space under represents the total amount present. In
MAT/ lungs, many more neutrophils were detected,
but few of these were seen free within the alveolar lumen Chemokine Compartmentalization
Based on these findings, we reasoned that matrilysin(Figure 4B). Instead, they were tightly apposed to the
alveolar walls and under high magnification (Figure 4C) regulates the activity of an epithelial-derived neutrophil
Cell
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Figure 5. Impaired KC Compartmentaliza-
tion in MAT/ Lungs
WT and MAT/ mice (n  6) were instilled
with 0.16 U bleomycin.
(A and E) BAL, (C) lung homogenates, and (D)
sera were harvested from control animals and
at 16 hr to 15 days postinstillation. KC and
MIP-2 protein levels were determined by
ELISA, shown as the mean  SE.
(B) Total RNA was isolated at 0 to 72 hr postin-
stillation, and KC mRNA was assessed by RT-
PCR/Southern hybridization.
chemotactic factor. We assessed the level of KC, a mu- for matrilysin (data not shown). To identify a candidate
substrate, we relied on four key bits of published infor-rine functional homolog of IL-8 and a structural homolog
of human GRO. KC, an 8 kDa member of the CXC mation. (1) IL-8, the human homolog of KC, must be
associated with heparan sulfate to have neutrophil che-chemokine family, is a potent and essential neutrophil
chemoattractant (Wiekowski et al., 2001) and is ex- motactic activity (Webb et al., 1993) and to bind its
receptor, CXCR2, with high affinity (Hoogewerf et al.,pressed by epithelial, endothelial, and interstitial cells
in a variety of inflammatory conditions, including models 1997). (2) Heparan sulfate is required for the IL-8-medi-
ated efflux of neutrophils through the endothelium ofof lung injury and infection (Heeckeren et al., 1997; Meh-
rad et al., 1999). In response to injury, KC is rapidly venules (Middleton et al., 1997). (3) Matrilysin docks
to heparan sulfate proteoglycans, and this associationexpressed and appears before many other chemokines
(Endlich et al., 2002; Rovai et al., 1998). enhances enzyme activity (Yu and Woessner, 2000). (4)
Syndecan proteoglycans, the principal source of cell-KC levels in BAL from WT lungs were markedly ele-
vated within 12 hr after bleomycin instillation and re- surface heparan sulfate, are shed in response to injury
and inflammation by a yet to be described metallopro-turned to controls levels by 3 days (Figure 5A), likely
due to clearance. In contrast, KC protein remained at teinase (Bernfield et al., 1999; Fitzgerald et al., 2000).
Syndecans, of which there are four gene products inor near to baseline levels in BAL from bleomycin-treated
MAT/mice (Figure 5A). Bleomycin-induced changes mammals, are type I transmembrane proteoglycans
found on essentially all adherent cells and have beenin other chemokines, namely MIP-2 (Figure 5E), eotaxin,
and MIP-1, did not differ between MAT/ and WT shown in vitro to interact with a variety of proteins, in-
cluding chemokines (Park et al., 2000b). Of these, synde-mice (data not shown). Based on mRNA levels, reduced
KC protein in the alveolar space of MAT/ mice was can-1 is abundantly expressed on the basal surface of
lung epithelial cells. Thus, we explored if syndecan-1not due to decreased gene expression (Figure 5B), and
elevated levels in the serum indicated that endothelial- was the matrilysin substrate involved in KC compart-
mentalization.derived KC was essentially equal in both mouse strains.
Of significance, KC protein levels remained fairly con- In untreated WT and MAT/mice, equivalent signal
for syndecan-1 was seen in the columnar epithelium ofstant in lung extracts from WT mice but accumulated
in lungs of MAT/ mice (Figure 5C). conducting airways and the cuboidal type II cells of the
alveoli (Figure 6A, D0), and similar levels of the proteo-
glycan were detected in detergent extracts of wholeLack of Syndecan-1 Shedding in MAT/ Mice
These data indicate that matrilysin acts on a protein that lung (Figure 6B, Lung). At 1 and 2 days post-bleomycin,
total syndecan-1 levels remained relatively unchangedfacilitates the distribution of KC from the interstitium to
the lumen. This protein is not KC; KC is not a substrate in both WT and MAT/ lungs (Figure 6B, Lung). Be-
Matrilysin Sheds Syndecan-1
641
Figure 6. Lack of Syndecan-1 Shedding in MAT/ Mice
(A) Lungs were harvested from WT and MAT/ (KO) mice before (D0) and 1 day (D1) postinstillation with 0.16 U bleomycin. Sections were
stained with antibody 281-2 against mouse syndecan-1 ectodomain. Images were viewed using DIC optics and inverted. In each image, the
lumen of a conducting airway is marked (*).
(B) Serial dilutions (l) of BAL and lung homogenates from WT and MAT/ controls (D0) and from mice at 1 and 2 days post-bleomycin
were immunoblotted with antibody 281-2 for shed syndecan-1. Similar results were obtained using either cationic or nitrocellulose membranes,
suggesting that shed syndecan-1 in WT BAL is bound to a protein.
(C) Attached NMuMG cells were incubated with the indicated amounts of pro-matrilysin, APMA-activated pro-matrilysin, or active matrilysin.
Shed syndecan-1 was quantified by dot immunoblot assay using pure mouse syndecan-1 as a standard. Data are mean  SE (n  3).
(D) HB-215 cells were incubated with 1 g/ml active matrilysin or 1 M phorbol ester (PMA). Shed syndecan-1 was assayed in serial dilutions
of 100 l medium by dot immunoblot. The cells were spun onto slides and stained without permeabilization for syndecan-1 ectodomain.
Increased recovery of shed syndecan-1 ectodomains in the medium was accompanied by a loss of the proteoglycan on the cell surface.
cause bleomycin causes focal injuries mostly in the alve- leased intact from damaged cells. We did not detect
any difference in the levels of shed syndecan-4 (data notolar compartment, we did not expect to see a noticeable
change in total lung syndecan-1. However, in bleomy- shown), another syndecan expressed by lung epithelia
(Park et al., 2001). To assess if matrilysin directly shedscin-treated WT lungs, we found numerous and extensive
areas of alveoli lacking staining for syndecan-1 and syndecan-1, we added the enzyme to cultures of synde-
can-1-expressing cells. APMA-activated pro-matrilysinslightly reduced signal in conducting airways (Figure
6A, WT/D1). Complementary to these observations, we and active matrilysin, but not pro-matrilysin, cleaved
syndecan-1 from normal murine mammary glanddetected a marked increase in soluble syndecan-1 in
BAL at 1 day post-bleomycin, and these levels were (NMuMG) cells (Figure 6C). Active matrilysin also shed
syndecan-1 from the surface of HB-215 mouse myelomareduced at day 2 (Figure 6B), likely indicating clearance
by the mucociliary apparatus or by endocytosis. cells similar to the release mediated by phorbol ester
(Figure 6D), a syndecan shedding agonist (Fitzgerald etIn bleomycin-treated MAT/ mice, however, both
the pattern and intensity of syndecan-1 staining did not al., 2000).
change compared to that seen in day 0 control lungs
(Figure 6A) and soluble syndecan-1 was not detected KC Associates with Shed Syndecan-1
We used two immunoprecipitation approaches to as-in BAL samples (Figure 6B). Syndecan-1 in WT BAL
was not detected with an antibody to the cytoplasmic sess if KC interacts with shed syndecan-1. In BAL sam-
ples from WT mice digested with heparinases and chon-domain (results not shown), verifying that the ectodo-
main was shed and that the proteoglycan was not re- droitinase ABC and blotted with a monoclonal antibody
Cell
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Figure 7. Syndecan-1/KC Interaction
(A) KC was immunoprecipitated (IP) from BAL of WT mice 1 day post-bleomycin. BAL and post-IP supernatants and pellets were electrophoresed
and blotted for syndecan-1 ectodomain. The arrowhead indicates the band specifically coprecipitated with KC.
(B) KC and syndecan-1 were immunoprecipitated from BAL of WT mice 1 day post-bleomycin. Two additional syndecan-1 IPs were done on
the post-IP supernatant. The level of KC protein in the BAL and in the post-IP supernatants was quantified by ELISA.
(C–E) WT and SYN1/ mice (n  3) were instilled with 0.15 U bleomycin. KC levels in BAL (C) and lung homogenates (D) were determined
by ELISA.
(E) Neutrophils (PMNs) in BAL were counted and expressed as a percent of total leukocytes. Data are the mean  SE.
against syndecan-1 ectodomains, we detected a band These findings provide further evidence that matrilysin,
syndecan-1, and KC coordinate and confine inflamma-of about 80 kDa, the size of the syndecan-1 ectodomain
core protein and non-specific bands at about 60 and 40 tion to sites of injury.
kDa (Figure 7A, BAL). BAL samples were then immuno-
precipitated with an anti-KC antibody, and the pellets Discussion
and supernatants were treated with heparinases and
chondroitinase ABC and blotted for syndecan-1. In Our study describes a mechanism in which three epithe-
lial components—a secreted proteinase (matrilysin), athese samples, the 80 kDa syndecan-1 core protein was
selectively coimmunoprecipitated with KC (Figure 7A, cell-bound proteoglycan (syndecan-1), and a chemo-
kine (KC)—act coordinately to direct inflammatory cellsIP Pellet) but was absent in the non-precipitated super-
natant (Figure 7A, IP Super). In addition, KC was effec- to injury sites. We identified syndecan-1, the predomi-
nant heparan sulfate proteoglycan on epithelia, as atively cleared from WT BAL with anti-KC antibodies and
by immunoprecipitating consecutively with anti-synde- substrate for matrilysin in vivo and in vitro and demon-
strate that shed syndecan-1 binds to and regulates thecan-1 antibodies (Figure 7B). Together, these results
demonstrate that KC is bound to syndecan-1 ectodo- activity of the chemokine KC in injured mouse lung.
We propose that in response to injury, epithelial cellsmains in BAL of bleomycin-instilled WT mice.
To determine if syndecan-1 is required for KC mobili- synthesize, secrete, and deposit KC (and possibly other
chemokines) onto the preexisting syndecan-1 mole-zation, we examined syndecan-1 null (SYN1/) mice.
Similar to MAT/ mice, SYN1/ are normal with no cules. Matrilysin is also induced by injury and secreted
by wound-edge epithelia (Figure 1E) and, as suggestedovert phenotype in unchallenged animals (Alexander et
al., 2000; Park et al., 2001). As we saw in MAT/ mice by the findings of others, may anchor to the heparan
sulfate chains of cell surface proteoglycans (Yu and(Figure 5A), KC levels in BAL of bleomycin-instilled
SYN1/mice remained at or near baseline levels (Fig- Woessner, 2000; Yu et al., 2002). Our data indicate that
matrilysin cleaves the syndecan-1 core protein to re-ure 7C), and the levels in lung tissue were elevated
compared to WT (Figure 7D). In addition and again simi- lease the ectodomain-KC complex. The shed complex
is then transported, either actively or passively, to thelar to MAT/ mice (Figure 3C), many less neutrophils
were recovered from the BAL of SYN1/ mice than apical surface creating a chemotactic gradient guiding
neutrophils into the alveolar space.of WT mice (Figure 7E). Elevated myeloperoxidase levels
in lung homogenates did not differ between SYN1/ Recently, two groups reported that matrilysin is prom-
inently expressed by the epithelium in human pulmonaryand WT bleomycin-instilled mice were similar (data not
shown) indicating that neutrophil movement into the fibrosis (Cosgrove et al., 2002; Zuo et al., 2002), confirm-
ing our earlier findings (Dunsmore et al., 1998). Zuo etlung was not impaired. Thus, lung alveolar inflammation
is attenuated in the absence of syndecan-1 or matrilysin. al. (2002) also showed a slight reduction in fibrosis in
Matrilysin Sheds Syndecan-1
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MAT/ mice at 14 days post-bleomycin, and we ob- (MMP-2) facilitates the formation of a transepithelial gra-
dient of interleukin-13 in allergen-challenged lung (Corrytained essentially the same data at 15 days (Figure 1C).
Although they concluded that matrilysin null mice are et al., 2002). The substrate MMP-2 cleaves to create
this gradient is not known. Because KC was not a sub-protected against bleomycin-induced fibrosis, our re-
sults indicate that the prominent and relevant phenotype strate for matrilysin, we hypothesized that this MMP
acts on a molecule that shuttles the chemokine fromin MAT/mice is an impaired efflux of neutrophils into
the alveolar space. We conclude that the slight reduction the basal surface of the epithelium into the alveolar
space. Our results indicate that syndecan-1 is the sub-in collagen deposition is a minor phenotype, likely a
downstream consequence of less acute alveolar injury. strate responsible for establishing a transepithelial che-
motactic gradient of KC within the injured lung. Synde-MAT/ mice were protected against bleomycin-
mediated lethality, particularly before significant fibrosis can-1 is shed by metalloproteinase cleavage of the
ectodomain at a site near the transmembrane domainwas detected (i.e., before day 15). Based on the number
of cells recovered from tissue and on histologic analyses (Fitzgerald et al., 2000) and occurs in cells and tissues
in response to injury, various inflammatory mediators,of lungs, neutrophils, as well as other inflammatory cells,
in MAT/ mice had no problem effluxing from the and virulence factors (Bernfield et al., 1999; Park et al.,
2000b). Like the expression of matrilysin, shedding ofvasculature into the tissue and migrating through the
interstitial space to the basal epithelial border. Because syndecan-1 is a common response of challenged epi-
thelia. The lack of syndecan-1 shedding in MAT/matrilysin is expressed by injured mucosa but not by
neutrophils or interstitial cells, we expected a phenotype mice following bleomycin injury, along with our in vitro
studies showing that matrilysin sheds syndecan-1 ecto-related to epithelial function. Our findings showed that
neutrophils in MAT/ lungs were stuck at the epithe- domains from cultured epithelial cells, indicates that this
MMP is a physiologic sheddase of this transmembranelial-matrix interface at 1 day post-bleomycin and accu-
mulated in perivascular spaces over the next few days. proteoglycan.
Our data also demonstrate that KC is bound to shedForcing neutrophils into the alveolar space by coinstilla-
tion of a bacterial chemotactic peptide, nFNLP, led to syndecan-1 ectodomains and that these complexes are
translocated into the alveolar space in a matrilysin-complete mortality of bleomycin-treated MAT/ mice
(Figure 3G), indicating that the protection seen in the dependent manner. Indeed, KC was detected in the al-
veolar space of WT but not of MAT/ or SYN1/knockout mice was due to confinement of neutrophils to
the subepithelial compartment. Thus, epithelial-derived mice. More important, KC was found in the BAL of WT
mice only when syndecan-1 ectodomains were also de-matrilysin regulates the transepithelial advancement of
neutrophils during the initial stages of injury, but to un- tected in this compartment—that is, the first 2 days
post bleomycin—despite the fact that KC expressionderstand this mechanism, we had to identify the en-
zyme’s substrate. continued beyond this time. Association with heparan
sulfate enhances both the neutrophil chemotactic activ-The reduced levels of KC in BAL concomitant with an
accumulation of the chemokine in the lungs of bleomy- ity of IL-8 (Webb et al., 1993), the human functional
homolog of KC, and the catalytic activity of matrilysincin-treated MAT/ mice provided an important clue
to uncovering the mechanism by which matrilysin regu- (Yu and Woessner, 2000). Thus, the heparan sulfate
chains of syndecan-1 seem to be the central compo-lates neutrophil movement. KC is a potent neutrophil
chemoattractant, and like matrilysin, it is rapidly induced nents of the epithelial machine that directs neutrophils
to sites of injury. Importantly, the parallel reduction of KCin epithelial cells in response to injury and infection.
Complementary to our findings, immunoablation of KC levels and neutrophils in BAL in MAT/ and SYN1/
mice underscore the cooperative function that matrilysinin lung injury models significantly reduces tissue dam-
age, presumably due to reduced neutrophil influx (Pic- and syndecan-1 serve in regulating chemokine compart-
mentalization and inflammation to sites of injury.colo et al., 1999; Yoshidome et al., 1999). Furthermore,
in various models of injury, infection, and inflammation, The observation that MAT/ mice are protected
against the acute injury and subsequent lethal effects ofthe influx and transepithelial migration of neutrophils
are significantly impaired in mice deficient for the KC bleomycin does not mean that this MMP is a detrimental
proteinase for the host. Indeed, matrilysin functions inreceptor CXCR2 or in mice treated with anti-CXCR2
antibodies (Del Rio et al., 2001; Godaly et al., 2000; Hall mucosal immunity, epithelial migration, and as shown
here, controlling neutrophil influx. Neutrophils compriseet al., 2001; Kielian et al., 2001; Olszyna et al., 2001).
Together with our data, these findings indicate that KC a major cellular component of host defense; for exam-
ple, patients with neutropenia and leukocyte adhesionis critical for directing the movement of neutrophils in
tissues. Compartmentalization of other chemokines, deficiency are susceptible to infection by opportunistic
microbial pathogens. However, with extensive injury,such as MIP-2, was similar between WT and MAT/
mice. Interestingly, neutralization of MIP-2 attenuates such as that produced with high doses of bleomycin, a
massive neutrophil influx would cause indiscriminate,bleomycin-induced pulmonary fibrosis independently of
neutrophil infiltration (Keane et al., 1999), which may severe, and potentially mortal tissue damage. We have
described what we believe to be a normal and requiredexplain why MAT/ mice still develop significant fi-
brosis. repair process, which, if unregulated and exuberant,
can be harmful. A lack of neutrophils and, in turn, theModulation of chemokine activity and compartmental-
ization by a metalloproteinase is not unprecedented. oxidative damage they can cause, would be consistent
with the protective effect we observed in the MAT/Various MMPs cleave monocyte chemoattractant pro-
teins resulting in either inactive or antagonistic chemo- mice.
Our data also suggest that the activation state of neu-kines (McQuibban et al., 2000, 2002). Gelatinase-A
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against mouse syndecan-1 cytoplasmic domain, or rat anti-mousetrophils is controlled by their location as they move
syndecan-4 monoclonal antibody (Ky8.2) as described (Park et al.,through tissue compartments. Although neutrophils
2001; Subramanian et al., 1997). Confluent cultures of NMuMG cellswere plentiful in the MAT/ lungs following bleomycin
in 96-well microtiter plates were incubated for 4 hr in 100 l medium
injury, the increased survival of these mice correlated without or with recombinant pro-matrilysin (Chemicon, Temecula,
with the inability of the granulocytes to cross the epithe- CA), pro-matrilysin activated with 1 mM APMA, or active matrilysin
(Wilson et al., 1999). HB-215 cells (5 107 cells/ml; ATCC, Manassas,lial barrier. If the neutrophils were induced to advance
VA) were incubated in suspension with 1 g/ml active matrilysin orinto the lumenal space, as we did with nFNLP (Figure
1 M PMA at 37C for 30 min serum-free medium.3G), then MAT/ mice died. We interpret these data
to mean that once the neutrophils have completed their
Immunoprecipitation
transepithelial trek into the lumenal space, they received Lavage (300 l) was precleared with protein G Sepharose 4B (PGS)
the appropriate signal, possibly from the epithelium, to and immunoprecipitated with 10 g rat anti-mouse KC antibody
be activated and initiate an oxidative burst and degranu- (R&D Systems) or 20 g 281-2 antibody as described (Dumin et al.,
2001). KC remaining in the immunoprecipitation supernatant waslation. It is reasonable that neutrophil activity would be
quantified by ELISA. In some experiments, syndecan-1 was reimmu-mostly restrained until the cells reach the lumen, where
noprecipitated twice from the post-wash supernatant. For Westernthey would encounter microorganisms. We are now ex-
blots of syndecan-1, glycosaminoglycans were removed before
ploring how matrilysin-mediated processes control neu- electrophesis by treating BAL samples and immunoprecipitates with
trophil activation. heparinases and chondroitinase ABC as described (Park et al.,
2000a).
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